Posts

Showing posts from January, 2023

Oral Pigmentation as a Sign of Addison’s disease

Abstract Addisonian skin hyperpigmentation, an important element of the pathology, is relatively rare, mucosal involvement is even less frequent. Likewise, there is little iconographic documentation of these pathologies. Addison’s disease is a primary adrenal failure caused by infiltrative or autoimmune processes. One of the most important signs of Addison’s disease is cutaneous and mucosal hyperpigmentation’s related to ACTH melanogenesis action. Pigmentation can be homogeneous or blotchy, it does not depend on gender or race. It may involve skin, oral cavity, conjunctiva and genitalia. It is more evident in areas exposed to the sun and under mechanical stimulations. Here, we describe a patient who was affected by brown maculae involving the oral cavity. Treatment with hydrocortisone allowed biological normalization and improvement of the general condition. Currently, the patient no longer has a systemic disorder, however the mucous hyperpigmentation persists. Read More About This Art...

Iris Publishers - Online Journal of Dentistry & Oral Health| Effects of Medications on Dental Implant Failure: A Review

Image
  Authored by   Elif Öncü *, Abstract Several studies have shown that some commonly prescribed drugs, including bisphosphonates (BP), proton pump inhibitors (PPI), selective serotonin reuptake inhibitors (SSRI), and non-steroidal anti-inflammatory drugs (NSAID), can affect peri-implant bone healing, remodeling, and osseointegration. In order to ensure successful osseointegration of dental implants, it is important to investigate the effects of systemic diseases and regularly used medications on osseointegration. Therefore, the aim of this review is to investigate the association between the intake of medications that may affect bone metabolism and implant outcomes. Keywords:  Anti-inflammatory drugs; Bisphosphonates; Drugs-related; Implant Failure; Proton Pump Inhibitors; Selective serotonin reuptake inhibitors Abbreviations:  PPI: Proton Pump Inhibitors; SSRI: Selective serotonin reuptake inhibitors; NSAIDs: Non-steroidal anti-inflammatory drugs; BP: bisphospho...